Fresenius sets final redemption price for 4% notes due 2024

By Mary-Katherine Stinson

Lexington, Ky., Nov. 27 – Fresenius SE & Co. KGaA announced the final price for the early redemption of its €450 million 4% notes due 2024 (ISIN: XS1026109543, XS1026109204) on Dec. 4, according to a notice.

The Rule 144A and Regulation S notes will be redeemed at par plus the make-whole amount of €89,695.40, calculated at Bunds plus 50 basis points.

Accrued interest will also be paid, totaling €13.67 per note, bringing the redemption price to €1,013.87 per note.

Fresenius is a German health care group. The company provides products and services for dialysis, hospitals, and outpatient medical care.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.